NGS-Based RNA-Sequencing Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities

The NGS-Based RNA-Sequencing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the NGS-Based RNA-Sequencing Market?
In recent times, the market size for NGS-based RNA-sequencing has experienced significant growth. The market value is projected to rise from $3.41 billion in 2024 ramping up to $4.23 billion in 2025, reflecting a compound annual growth rate (CAGR) of 24.2%. This surge during the historical period can be linked to factors such as initiatives in genomic research, reduced sequencing expenses, advancements in drug discovery and development, personalized medicine, and an uptick in NGS adoption.

Anticipated to experience rapid expansion in the coming years, the NGS-based RNA-sequencing market is projected to reach a value of $10.4 billion by 2029, with a compound annual growth rate (CAGR) of 25.2%. This growth over the forecast period can be linked to a variety of factors including clinical diagnostics, global partnerships, the establishment of ethical and regulatory frameworks, as well as agricultural and environmental studies, and green genomics. Some key trends to look out for during the forecast period encompass single-cell rna-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, the integration of multi-omics, and sustainable farming.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7416

What Are the Different NGS-Based RNA-Sequencing Market Segments?
The ngs-based rna-sequencing market covered in this report is segmented -

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management
2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing
3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics
4) By End User: Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:
1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents
2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables
3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services
4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

What Are the Primary Drivers Shaping the NGS-Based RNA-Sequencing Market?
The NGS-based RNA sequencing market is being propelled by advances in precision medicine. Precision medicine enables physicians to devise tailored treatment strategies and make therapeutic decisions based on a genetic comprehension of the patient's ailment. There's a rising trend in precision medicines to tackle serious diseases, such as cancer. The NGS-based RNA sequencing aids in pinpointing the root cause of the disease and prescribing the appropriate precision medicine for treatment. For example, a report from the Personalized Medicine Coalition (PMC), a non-profit organization based in the US, stated in February 2023 that personalized medicines made up 35% of newly approved NMEs in 2021, and with 12 new approvals in 2022, they've consistently claimed at least a quarter of new drug approvals over the past eight years. This represents a significant rise from less than 10% a decade ago. As precision medicine demand grows, so will the need for NGS-based RNA sequencing.

Which Companies Are Leading in the NGS-Based RNA-Sequencing Market?
Major companies operating in the ngs-based rna-sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, Dickinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

What Are the Major Trends Shaping the NGS-Based RNA-Sequencing Market?
One significant trend in the NGS-based RNA sequencing market is Strategic Partnership. Numerous companies are seeking collaborations with NGS-based RNA sequencing firms with the goal of penetrating new markets and mutual resource utilization. For example, The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services, established partnerships with several industrial and academic affiliates in May 2022. The aim of these partnerships is to enhance the ability to quickly address public health crises and initiate the development of a unique diagnostic tool that identifies all known and emerging respiratory RNA viruses through a singular test.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

What Are the Top Revenue-Generating Geographies in the NGS-Based RNA-Sequencing Market?
North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the NGS-Based RNA-Sequencing Market?
2. What is the CAGR expected in the NGS-Based RNA-Sequencing Market?
3. What Are the Key Innovations Transforming the NGS-Based RNA-Sequencing Industry?
4. Which Region Is Leading the NGS-Based RNA-Sequencing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.